Healthcare Providers and Services
Company Overview of Main Line Health, Inc.
Main Line Health, Inc., a non-profit health system, operates a chain of hospitals and medical centers that provide various health care services. It offers addiction, allergy and immunology, arthritis, audiology and hearing aids, bariatric medicine, behavioral health, breast health, cancer, cardiac rehabilitation, cardiology, cardiovascular and thoracic surgery, celiac center, childbirth education, clinical trials, community health, dentistry, dermatology, diabetes management, diagnostic radiology, emergency medicine, endocrinology and metabolic diseases, endoscopy, enterostomal therapy, family medicine, foot conditions, and gastroenterology services. The company also provides general surgery...
130 South Bryn Mawr Avenue
Bryn Mawr, PA 19010
Founded in 1985
Key Executives for Main Line Health, Inc.
Chief Executive Officer, President and Member of Board of Trustees
Chief Financial Officer and Executive Vice President
Chief Executive Officer of Lankenau Insititute of Medical Research and President of Lankenau Insititute of Medical Research
Chief Executive Officer of Mirmont Treatment Center and President of Mirmont Treatment Center
President of Paoli Hospital
Compensation as of Fiscal Year 2016.
Main Line Health, Inc. Key Developments
Main Line Health Announces Executive Changes
Jan 29 16
William A. Gray, MD, an interventional cardiologist and nationally recognized leader in endovascular and structural cardiac medicine, has been appointed System Chief of the Division of Cardiovascular Disease at Main Line Health. He succeeds Peter Kowey, MD, who provided tremendous leadership in this role for more than 25 years. Dr. Gray has also been named the first president of Main Line Health's Lankenau Heart Institute, the System's comprehensive cardiovascular medicine and surgery program. In his new role, Dr. Gray will continue to strengthen and enhance the medical and interventional programs offered through Lankenau Heart Institute, while preparing the cardiovascular division of Main Line Health for success in this dynamic health care landscape. In collaboration with specialists across the System, Dr. Gray will also lend his expertise in coronary, structural and endovascular interventions to expand the scope of advanced nonsurgical treatments. Dr. Gray will also be working closely with the Lankenau Institute of Medical Research (LIMR) on a variety of research projects. Dr. Gray has served in cardiovascular leadership roles for nearly 20 years, most recently as Director of Endovascular Services at New York-Presbyterian/Columbia University Medical Center.
Main Line Health Partners with Brandywine At Haverford Estates
Jan 26 16
Main Line Health has expanded their partnership with Brandywine to include Brandywine Senior Living at Haverford Estates to bring high-quality medical care, fitness classes and wellness education to residents at their assisted living community located at 731 Old Buck Lane. Through this collaboration, Main Line Health and its affiliates will offer Brandywine residents the following on-site services: Health care coordination between Main Line Health and their affiliated health care providers and Brandywine’s licensed nursing team; Fitness Classes; Health and Wellness education programs. Brandywine Senior Living and Main Line Health will continue to develop and bring additional programs and services into the community in 2016.
Charles Antzelevitch Joins Lankenau Institute for Medical Research and Director of Research at Lankenau Heart Institute as Executive Director
Jul 22 15
Main Line Health has named Charles Antzelevitch, PhD, FACC, FAHA, FHRS, Executive Director of the Cardiovascular Research Program at Lankenau Institute for Medical Research and Director of Research at Lankenau Heart Institute. Dr. Antzelevitch is an internationally recognized expert in cardiac electrophysiology and arrhythmia syndromes. In his new role at Main Line Health, he will assemble a cardiovascular research team of clinical investigators and basic scientists to advance understanding of the underlying mechanisms of cardiac arrhythmias and to translate these discoveries into novel approaches to therapy. Dr. Antzelevitch joins Main Line Health after more than 31 years as Executive Director, Director of Research, and Gordon K. Moe Scholar (endowed Chair in Experimental Cardiology) at the Masonic Medical Research Laboratory in Utica, NY. He also holds an academic appointment as Professor of Pharmacology at SUNY Upstate Medical University in Syracuse, NY.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|